If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
IBA and Philips Healthcare announced the signing of a global collaboration to provide advanced diagnostic and therapeutic solutions for the treatment of cancer.
Angiographic imaging system vendors have developed several new technologies to address emerging cath lab trends, including the need to reduce radiation dose, improve image quality and enable advanced procedural image guidance. All three of these points have become increasingly important as more complex procedures are attempted in interventional cardiology cath labs and hybrid ORs. These procedures include transcatheter aortic valve replacement (TAVR), mitral clip valve repairs, left atrial appendage (LAA) occlusions, atrial and ventricular septal defect closures, and new interventions for both electrophysiology (EP) and heart failure.
Arc-based radiation therapy continues to gain ground as physicians opt for treatment options that not only are more precisely tailored to each tumor site, but also delivered in fewer visits, which is significantly more convenient for both patients and cancer centers. With a variety of radiation therapy techniques available, from intensity-modulated radiation therapy (IMRT) and whole-body irradiation (WBI) to proton therapy and stereotactic body radiation therapy (SBRT), cancer centers around the country are now, more than ever, able to offer patients a more effective solution for targeting and treating their diseases.
Philips has launched Affiniti. The new ultrasound system made its debut at the European Society of Cardiology (ESC) Congress 2014 in Barcelona.
August 27, 2014 — Philips Healthcare announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its precision planning application for transcatheter aortic valve implantation (TAVI) treatments.
August 12, 2014 — Elekta and Philips Healthcare announced The Christie NHS Foundation Trust, a specialist cancer center based in Manchester, England, will join a consortium whose mission is to develop the clinical value of an integrated magnetic resonance imaging (MRI)-guided radiation therapy system. Such a system would, in principle, improve the practice of radiotherapy via real-time visualization of cancer targets.
Intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) planning is a time-consuming and labor-intensive process often producing inconsistent results.
August 1, 2014 — Thousands of healthcare providers weighed in to identify this year's top-performing vendor solutions in 23 different medical equipment and infrastructure categories. The "2014 Best in KLAS: Medical Equipment and Infrastructure" report is the culmination of feedback from providers throughout the world.
The key take away message from the Society of Cardiovascular Computed Tomography (SCCT) annual meeting in July was that CT technology is advancing rapidly and there is a strong feeling it will become the pre-eminent cardiac imaging modality.
Philips Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ultra mobile ultrasound system, Visiq, in the U.S. The system is the first Philips ultrasound system to combine the benefits of greater mobility, performance and simplicity into a single miniaturized solution, helping clinicians increase access to quality diagnostic scans for more OB patients.